Mark Lew

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia

Mitchell F. Brin, Mark Lew, Charles H. Adler et al. · Neurology · 1999 · 444 citations

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystonia

Allison Brashear, Mark Lew, D.D. Dykstra et al. · Neurology · 1999 · 300 citations

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study

Daniel Truong, Drake D. Duane, Joseph Jankovic et al. · Movement Disorders · 2005 · 240 citations

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

Mark Lew, Bruce T. Adornato, Drake D. Duane et al. · Neurology · 1997 · 240 citations

Placebo-controlled Safety, Pain Therapy, Pain Syndrome +13

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 236 citations · Full text